Glumetinib: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
1
US states with sites
3
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| C-Met Exon 14 Mutation | 1 |
| Non-Small Cell Lung Cancer | 1 |
Recruiting trials involving Glumetinib
- A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
- Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
Common questions
How many recruiting trials involve Glumetinib?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.